Further investigation using propidium iodide/calcein-acetoxymethyl (PI/calcein-AM) staining substantiated that ferrostatin treatment markedly impaired the killing of GBM cells by CD8+ T cells that had been induced by TRAF3 overexpression (Figure 8F and Supplemental Figure 8F). The gene discussed is TRAF3; the disease is glioblastoma.